APA citáció

Clowse Megan E. B., Wallace Daniel J., Furie Richard A., Petri Michelle A., Pike Marilyn C., Leszczynski Piotr, . . . et al. (2017). Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.

Chicago Style (17th ed.) Citation

Clowse Megan E. B., et al. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. John Wiley and Sons, Inc, 2017.

MLA idézés

Clowse Megan E. B., et al. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. 2017.